Radiolabeled antibody, stem cell transplant treat leukemia

11/5/2009 | EurekAlert!

Researchers used an antibody attached to iodine 131 to target leukemic blood cells for radiation delivery among patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndrome, a pre-leukemic condition. The technique allowed for more radiation to reach and eliminate cancer cells in preparation for stem cell transplantation. All of the patients in the study experienced a remission in their cancers after undergoing the combined procedure.

View Full Article in:

EurekAlert!

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC